ZA919196B - New and useful excitatory amino acid antagonist - Google Patents

New and useful excitatory amino acid antagonist

Info

Publication number
ZA919196B
ZA919196B ZA919196A ZA919196A ZA919196B ZA 919196 B ZA919196 B ZA 919196B ZA 919196 A ZA919196 A ZA 919196A ZA 919196 A ZA919196 A ZA 919196A ZA 919196 B ZA919196 B ZA 919196B
Authority
ZA
South Africa
Prior art keywords
amino acid
excitatory amino
useful
new
acid antagonist
Prior art date
Application number
ZA919196A
Inventor
Greg Scott Hamilton
Scott Hamilton Greg
Original Assignee
Nova Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nova Pharm Corp filed Critical Nova Pharm Corp
Publication of ZA919196B publication Critical patent/ZA919196B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/383—Cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

An unexpectedly more potent isomer of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid, a known excitatory amino acid antagonist, pharmaceutical compositions including this isomer and methods of using this isomer to antagonize excitatory amino acid receptors.
ZA919196A 1990-12-07 1991-11-20 New and useful excitatory amino acid antagonist ZA919196B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62416890A 1990-12-07 1990-12-07

Publications (1)

Publication Number Publication Date
ZA919196B true ZA919196B (en) 1992-09-30

Family

ID=24500939

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919196A ZA919196B (en) 1990-12-07 1991-11-20 New and useful excitatory amino acid antagonist

Country Status (11)

Country Link
EP (1) EP0639197B1 (en)
JP (1) JP2721933B2 (en)
AT (1) ATE142220T1 (en)
CA (1) CA2097910A1 (en)
DE (1) DE69121920T2 (en)
DK (1) DK0639197T3 (en)
ES (1) ES2094338T3 (en)
GR (1) GR3021881T3 (en)
IE (1) IE75735B1 (en)
WO (1) WO1992010099A1 (en)
ZA (1) ZA919196B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028213A (en) 1998-04-16 2000-02-22 Eastman Chemical Company Optically active cis-1,3-cyclohexanedicarboxylic acid monoesters with high enantiomeric purity and process for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761405A (en) * 1987-03-04 1988-08-02 Nova Pharmaceutical Corporation Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency

Also Published As

Publication number Publication date
DE69121920D1 (en) 1996-10-10
IE75735B1 (en) 1997-09-24
DE69121920T2 (en) 1997-04-03
EP0639197A4 (en) 1994-02-21
WO1992010099A1 (en) 1992-06-25
CA2097910A1 (en) 1992-06-08
ES2094338T3 (en) 1997-01-16
DK0639197T3 (en) 1997-02-24
EP0639197B1 (en) 1996-09-04
JPH06505966A (en) 1994-07-07
GR3021881T3 (en) 1997-03-31
JP2721933B2 (en) 1998-03-04
IE914256A1 (en) 1992-06-17
EP0639197A1 (en) 1995-02-22
ATE142220T1 (en) 1996-09-15

Similar Documents

Publication Publication Date Title
EA199700260A1 (en) READY PREPARATIVE FORM OF 2-METHYLTIENOBENZODIAZEPINA FOR ORAL ADMINISTRATION AND METHOD FOR ITS PREPARATION
LU91145I2 (en) FIROCOXIB optionally in the form of a pharmaceutically acceptable salt (PREVICOX).
NZ236581A (en) 3-amino piperidine derivatives, analogues and pharmaceutical compositions
KR900012911A (en) Excitatory Amino Acid Receptor Antagonist Compound
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
IT1137271B (en) MERCAPTOACIL DERIVATIVES OF VARIOUS PROLINES 4 REPLACED AND RELEVANT USEFUL COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION
IT1226847B (en) FEMORAL COMPONENT FOR A HIP PROSTHESIS
NO944578L (en) Excitatory amino acid receptor antagonists
HUT55369A (en) Herbicidal compositions and process for producing sulfonylamino-carbonyl triazolinone derivatives and their intermediates used as active ingredient
EP0394905A3 (en) Excitatory amino acid antagonists
MX9801890A (en) Novel human nk3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them.
HUT67237A (en) Excitatory amino acid antagonists indole derivatives, their preparation and pharmaceutical compositions comprising them
PT927184E (en) DERIVATIVES OF 3-SUBSTITUTED PYRID-¬4 ', 3': 4,5 | -ENENE- ¬ 2,3-D | -PYRIMIDINE SUBSTITUTES FOR THEIR PRODUCTION AND THEIR USE
IL94377A (en) Pyridine derivatives which antagonize the effects of excitatory amino acids upon the nmda receptor complex and pharmaceutical compositions comprising them
FI93210B (en) Process for the preparation of a virus-antagonizing compound
DK0617616T3 (en) Potentiation of NMDA antagonists
DK0639197T3 (en)
MX9708557A (en) New pharmacological use of aii-receptor antagonists.
UA41300C2 (en) Analogs of hormones-antagonists of LHRH and a method for the preparation thereof
AU8653891A (en) Amino acid analogs as cck antagonists
DE68902490D1 (en) PHARMACEUTICAL COMPOSITION.
ZA916918B (en) Amino acid analogs as CCK antagonists.
FI890678A (en) Analogous process for the preparation of therapeutically useful 1,3-dioxane alkenic acid derivatives
HUT67301A (en) Nmda antagonists quinolinic derivatives, their preparation and pharmaceutical compositions comprising them
IT8820542A0 (en) DIASTEREOSELECTIVE PROCESS FOR THE PREPARATION OF INTERMEDIATE USEFUL FOR THE SYNTHESIS OF PEPTIDE DERIVATIVES.